about
Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cellsCalcitonin receptor plays a physiological role to protect against hypercalcemia in miceOsteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorptionMechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.Experimental evidence for the effects of calcium and vitamin D on bone: a review.Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome.Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.The effect of Vdr gene ablation on global gene expression in the mouse placenta.The skeleton as an intracrine organ for vitamin D metabolism.Vitamin D(3) signalling to mast cells: A new regulatory axis.Vitamin D metabolism within bone cells: effects on bone structure and strength.Vitamin D actions to regulate calcium and skeletal homeostasis.The pleiotropic effects of vitamin D in bone.Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells.Vitamin D activities and metabolic bone disease.Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation.Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume.Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D3 on the mature osteoblast cell line MLO-A5.Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D3.Identification of vitamin D3 target genes in human breast cancer tissue.1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion.1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells.Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice.Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis.The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model.Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts.
P50
Q24305059-D68D08DD-BB1C-4BCA-9253-025B6F0631B2Q24646547-BFFDD96B-4ABA-400B-A386-6E4037FADF51Q28291550-52EAF391-FE78-4F07-BB32-0F42CB41194FQ34133575-858DA957-36FA-4277-A9F1-4DC2B4E85308Q35671093-F9E7ABD2-4B35-458A-9BD1-5E8E898A916AQ35677100-F02F4239-0FCD-41A5-A23F-017F281D3048Q35765530-3B54FED7-78EE-458C-9140-AE0F00F62115Q36332922-2D5B8AA6-C50F-4507-A4DD-59BE20FAE318Q37207672-1E042F0F-70CD-49FE-BB8A-DF6E7F3D49CCQ37802949-83454D64-DD81-4310-A489-04DD01D5E3D9Q37887981-7BF21D12-F6C8-410C-8CC9-20C1E09F8DABQ37993334-F834C7FA-BF9D-45B1-9481-9912BE7D49F4Q38043803-3ABD059C-7E82-48DA-B9E1-DD0B0ABAAA5EQ38044513-7DB8711D-C397-4096-A9E7-46826FA06B7CQ38051976-4174D4E8-847A-47CA-A348-A2EF7F707A1FQ38126275-2FD61DD7-EBB8-44F0-BEE2-5494DCFF7040Q38134837-69ED0409-99F7-4E0C-9F67-1B5BD89E4D22Q38152175-3619BE3E-8686-46A5-AE13-D2FF7A004B81Q38152528-28942C94-B6C4-4B79-899A-CF2094A0ABEDQ38168972-847D01F6-1629-4E00-A88A-ED7E9FB340F0Q38179164-D00E23F1-AC5F-45D0-8802-A538BD11D5F1Q38788422-1B5BFDA3-A153-4538-9D15-683971649479Q38809982-48AAC2C0-5DEE-486D-93C2-A26D8619649BQ38826367-CA5B12C6-2D95-4CE4-9FF2-67E30A025676Q38860041-3A3C572D-3620-404D-A077-1D5F2E8B9EFCQ38866161-D2272F76-077C-43F1-ABBB-B8E13FDA292AQ39143854-7F1689F0-3298-46B7-8899-30420D812F70Q39725352-542DDAA6-456A-4E5F-A8F1-5D8161A66EB2Q39838526-68276652-88F2-43B3-9A36-11E80A34B667Q40152168-DBE9E83F-647E-4853-9588-17920DDEE7C6Q40185123-82853E7A-0C86-4482-8AC0-3AFB1E3D345DQ40240264-339ABDEB-F6BA-43F2-8075-68F0F92EB4E3Q40775024-DD739CC1-9E1B-4B1C-BC58-E62D28BD47D6Q42905527-8AA0B5AA-8C02-49DD-B2B1-2AF411BA885BQ44546637-EA155DCC-4154-4E7F-8BFD-DF39BC9091CAQ44958178-DB774D94-3A3C-4529-BB14-B2F10809B3F4Q46277134-2923341F-B025-4AB6-940D-06BC476493FCQ46394734-DD745297-876F-4243-AA37-59BD441AEBFDQ47267472-8612B93F-7014-4456-85DB-EC44E21CFACFQ51576974-D10D6DD9-C535-4554-9A31-CCDFECA6BED9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paul H Anderson
@ast
Paul H Anderson
@en
Paul H Anderson
@es
Paul H Anderson
@nl
Paul H Anderson
@sl
type
label
Paul H Anderson
@ast
Paul H Anderson
@en
Paul H Anderson
@es
Paul H Anderson
@nl
Paul H Anderson
@sl
prefLabel
Paul H Anderson
@ast
Paul H Anderson
@en
Paul H Anderson
@es
Paul H Anderson
@nl
Paul H Anderson
@sl
P106
P1153
7404424723
P21
P31
P496
0000-0002-8685-3252